Ubiquitylation, neddylation and the DNA damage response

Open Biology

Volumn 5, Issue 4, 2015, Pages

  Brown, Jessica S ^a   Jackson, Stephen P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

DNA damage response; Double strand break repair; MLN4924; NEDD8; Ubiquitin

Indexed keywords

DNA; DNA BINDING PROTEIN; NEDD8 PROTEIN, HUMAN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE;

BIOLOGICAL MODEL; DNA DAMAGE; DNA REPAIR; GENETICS; HUMAN; METABOLISM; PROTEIN PROCESSING; UBIQUITINATION;

DNA; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; HUMANS; MODELS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; UBIQUITINS;

EID: 84933073669     PISSN: None     EISSN: 20462441     Source Type: Journal    
DOI: 10.1098/rsob.150018     Document Type: Review

References (331)

1. Jackson SP, Bartek J. 2009 The DNA-damage response in human biology and disease. Nature 461, 1071-1078. (doi:10.1038/nature08467)
2. Ciccia A, Elledge SJ. 2010 The DNA damage response: making it safe to play with knives. Mol. Cell 40, 179-204. (doi:10.1016/j.molcel.2010.09.019)
3. Polo SE, Jackson SP. 2011 Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev. 25, 409-433. (doi:10.1101/gad.2021311)
4. Lindahl T. 1993 Instability and decay of the primary structure of DNA. Nature 22, 709-715. (doi:10.1038/362709a0)
5. Bassing CH, Alt FW. 2004 The cellular response to general and programmed DNA double strand breaks. DNA Repair 3, 781-796. (doi:10.1016/j.dnarep.2004.06.001)
6. Schlissel MS, Kaffer CR, Curry JD. 2006 Leukemia and lymphoma: a cost of doing business for adaptive immunity. Genes Dev. 20, 1539-1544. (doi:10.1101/gad.1446506)
7. Richardson C, Horikoshi N, Pandita TK. 2004 The role of the DNA double-strand break response network in meiosis. DNA Repair 3, 1149-1164. (doi:10.1016/j.dnarep.2004.05.007)
8. Basu B, Yap TA, Molife LR, de Bono JS. 2012 Targeting the DNA damage response in oncology: past, present and future perspectives. Curr. Opin. Oncol. 24, 316-324. (doi:10.1097/CCO.0b013e32835280c6)
9. Curtin NJ. 2012 DNA repair dysregulation from cancer driver to therapeutic target. Nat. Rev. Cancer 12, 801-817. (doi:10.1038/nrc3399)
10. Furgason JM, Bahassi EM. 2013 Targeting DNA repair mechanisms in cancer. Pharmacol. Ther. 137, 298-308. (doi:10.1016/j.pharmthera.2012.10.009)
11. Griffith AJ, Blier PR, Mimori T, Hardin JA. 1992 Ku polypeptides synthesized in vitro assemble into complexes which recognize ends of double-stranded DNA. J. Biol. Chem. 267, 331-338.
12. Mimori T, Hardin JA, Steitz JA. 1986 Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders. J. Biol. Chem. 261, 2274-2278.
13. Smider V, Rathmell WK, Lieber MR, Chu G. 1994 Restoration of X-ray resistance and V(D)J recombination in mutant cells by Ku cDNA. Science 266, 288-291. (doi:10.1126/science.7939667)
14. Taccioli GE et al. 1994 Ku80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science 265, 1442-1445. (doi:10.1126/science.8073286)
15. Mari P-O et al. 2006 Dynamic assembly of endjoining complexes requires interaction between Ku70/80 and XRCC4. Proc. Natl Acad. Sci. USA 103, 18 597-18 602. (doi:10.1073/pnas.0609061103)
16. Britton S, Coates J, Jackson SP. 2013 A new method for high-resolution imaging of Ku foci to decipher mechanisms of DNA double-strand break repair. J. Cell Biol. 202, 579-595. (doi:10.1083/jcb.201303073)
17. Uematsu N et al. 2007 Autophosphorylation of DNA-PKCS regulates its dynamics at DNA doublestrand breaks. J. Cell Biol. 177, 219-229. (doi:10.1083/jcb.200608077)
18. Ramsden DA, Gellert M. 1998 Ku protein stimulates DNA end joining by mammalian DNA ligases: a direct role for Ku in repair of DNA double-strand breaks. EMBO J. 17, 609-614. (doi:10.1093/emboj/17.2.609)
19. Cary RB, Peterson SR, Wang J, Bear DG, Bradbury EM, Chen DJ. 1997 DNA looping by Ku and the DNA-dependent protein kinase. Proc. Natl Acad. Sci. USA 94, 4267-4272. (doi:10.1073/pnas.94.9.4267)
20. De Vries E, van Driel W, Bergsma WG, Arnberg AC, van der Vliet PC. 1989 HeLa nuclear protein recognizing DNA termini and translocating on DNA forming a regular DNA-multimeric protein complex. J. Mol. Biol. 208, 65-78. (doi:10.1016/0022-2836(89)90088-0)
21. Gottlieb T, Jackson S. 1993 The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell 72, 131-142. (doi:10.1016/0092-8674(93)90057-W)
22. Smith GC, Jackson SP. 1999 The DNA-dependent protein kinase. Genes Dev. 13, 916-934. (doi:10.1101/gad.13.8.916)
23. Costantini S, Woodbine L, Andreoli L, Jeggo PA, Vindigni A. 2007 Interaction of the Ku heterodimer with the DNA ligase IV/Xrcc4 complex and its regulation by DNA-PK. DNA Repair 6, 712-722. (doi:10.1016/j.dnarep.2006.12.007)
24. Hsu HL, Yannone SM, Chen DJ. 2002 Defining interactions between DNA-PK and ligase IV/XRCC4. DNA Repair 1, 225-235. (doi:10.1016/S1568-7864(01)00018-0)
25. Yano K, Morotomi-Yano K, Wang S-Y, Uematsu N, Lee K-J, Asaithamby A, Weterings E, Chen DJ. 2008 Ku recruits XLF to DNA double-strand breaks. EMBO Rep. 9, 91-96. (doi:10.1038/sj.embor.7401137)
26. Ochi T et al. 2015 PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA doublestrand break repair. Science 347, 185-188. (doi:10.1126/science.1261971)
27. Xing M et al. 2015 Interactome analysis identifies a new paralogue of XRCC4 in non-homologous end joining DNA repair pathway. Nat. Commun. 6, 6233. (doi:10.1038/ncomms7233)
28. Dolganov GM, Maser RS, Novikov A, Tosto L, Chong S, Bressan DA, Petrini JH. 1996 Human Rad50 is physically associated with human Mre11: identification of a conserved multiprotein complex implicated in recombinational DNA repair. Mol. Cell. Biol. 16, 4832-4841.
29. Ogawa H, Johzuka K, Nakagawa T, Leem SH, Hagihara AH. 1995 Functions of the yeast meiotic recombination genes, MRE11 and MRE2. Adv. Biophys. 31, 67-76. (doi:10.1016/0065-227X(95) 99383-Z)
30. Trujillo KM, Yuan SS, Lee EY, Sung P. 1998 Nuclease activities in a complex of human recombination and DNA repair factors Rad50, Mre11, and p95. J. Biol. Chem. 273, 21 447-21 450. (doi:10.1074/jbc.273.34.21447)
31. Usui T, Ohta T, Oshiumi H, Tomizawa J, Ogawa H, Ogawa T. 1998 Complex formation and functional versatility of Mre11 of budding yeast in recombination. Cell 95, 705-716. (doi:10.1016/S0092-8674(00)81640-2)
32. De Jager M, Dronkert ML, Modesti M, Beerens CE, Kanaar R, van Gent DC. 2001 DNA-binding and strand-annealing activities of human Mre11: implications for its roles in DNA double-strand break repair pathways. Nucleic Acids Res. 29, 1317-1325. (doi:10.1093/nar/29.6.1317)
33. Paull TT, Gellert M. 1998 The 30 to 50 exonuclease activity of Mre 11 facilitates repair of DNA doublestrand breaks. Mol. Cell 1, 969-979. (doi:10.1016/S1097-2765(00)80097-0)
34. Paull TT, Gellert M. 1999 Nbs1 potentiates ATPdriven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex. Genes Dev. 13, 1276-1288. (doi:10.1101/gad.13.10.1276)
35. Jazayeri A, Falck J, Lukas C, Bartek J, Smith GCM, Lukas J, Jackson SP. 2006 ATM- and cell cycledependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol. 8, 37-45. (doi:10.1038/ncb1337)
36. Sartori A, Lukas C, Coates J, Mistrik M, Fu S. 2007 Human CtIP promotes DNA end resection. Nature 450, 509-514. (doi:10.1038/nature06337)
37. Falck J, Coates J, Jackson SP. 2005 Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434, 605-611. (doi:10.1038/nature03442)
38. Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y. 2003 Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22, 5612-5621. (doi:10.1093/emboj/cdg541)
39. Lee J-H, Paull TT. 2005 ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 308, 551-554. (doi:10.1126/science.1108297)
40. Lamarche BJ, Orazio NI, Weitzman MD. 2010 The MRN complex in double-strand break repair and telomere maintenance. FEBS Lett. 584, 3682-3695. (doi:10.1016/j.febslet.2010.07.029)
41. Weinfeld M, Chaudhry MA, D'Amours D, Pelletier JD, Poirier GG, Povirk LF, Lees-Miller SP. 1997 Interaction of DNA-dependent protein kinase and poly(ADP-ribose) polymerase with radiation-induced DNA strand breaks. Radiat. Res. 148, 22-28. (doi:10.2307/3579534)
42. Bramson J, Pre?vost J, Malapetsa A, Noë AJ, Poirier GG, DesNoyers S, Alaoui-Jamali M, Panasci L. 1993 Poly(ADP-ribose) polymerase can bind melphalan damaged DNA. Cancer Res. 53, 5370-5373.
43. D'Silva I, Pelletier JD, Lagueux J, D'Amours D, Chaudhry MA, Weinfeld M, Lees-Miller SP, Poirier GG. 1999 Relative affinities of poly(ADP-ribose) polymerase and DNA-dependent protein kinase for DNA strand interruptions. Biochim. Biophys. Acta 1430, 119-126. (doi:10.1016/S0167-4838(98) 00278-7)
44. El-Khamisy SF, Masutani M, Suzuki H, Caldecott KW. 2003 A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. Nucleic Acids Res. 31, 5526-5533. (doi:10.1093/nar/gkg761)
45. Mortusewicz O, Rothbauer U, Cardoso MC, Leonhardt H. 2006 Differential recruitment of DNA ligase I and III to DNA repair sites. Nucleic Acids Res. 34, 3523-3532. (doi:10.1093/nar/gkl492)
46. Wang M, Wu W, Wu W, Rosidi B, Zhang L, Wang H, Iliakis G. 2006 PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res. 34, 6170-6182. (doi:10.1093/nar/gkl840)
47. Chapman JR, Taylor MRG, Boulton SJ. 2012 Playing the end game: DNA double-strand break repair pathway choice. Mol. Cell 47, 497-510. (doi:10.1016/j.molcel.2012.07.029)
48. Jha DK, Pfister SX, Humphrey TC, Strahl BD. 2014 SET-ting the stage for DNA repair. Nat. Struct. Mol. Biol. 21, 655-657. (doi:10.1038/nsmb.2866)
49. Kim S-T, Lim D-S, Canman CE, Kastan MB. 1999 Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 274, 37 538-37 453. (doi:10.1074/jbc.274.53.37538)
50. Matsuoka S et al. 2007 ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316, 1160-1166. (doi:10.1126/science.1140321)
51. Mahaney BL, Meek K, Lees-Miller SP. 2009 Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem. J. 417, 639-650. (doi:10.1042/BJ20080413)
52. Wang C, Lees-Miller SP. 2013 Detection and repair of ionizing radiation-induced DNA double strand breaks: new developments in nonhomologous end joining. Int. J. Radiat. Oncol. Biol. Phys. 86, 440-449. (doi:10.1016/j.ijrobp.2013.01.011)
53. Kaidi A, Jackson SP. 2013 KAT5 tyrosine phosphorylation couples chromatin sensing to ATM signalling. Nature 498, 70-74. (doi:10.1038/nature12201)
54. Costanzo V, Shechter D, Lupardus PJ, Cimprich KA, Gottesman M, Gautier J. 2003 An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication. Mol. Cell 11, 203-213. (doi:10.1016/S1097-2765(02)00799-2)
55. Zou L, Elledge SJ. 2003 Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300, 1542-1548. (doi:10.1126/science.1083430)
56. Cimprich KA, Cortez D. 2008 ATR: an essential regulator of genome integrity. Nat. Rev. Mol. Cell Biol. 9, 616-627. (doi:10.1038/nrm2450)
57. Nam EA, Cortez D. 2011 ATR signalling: more than meeting at the fork. Biochem. J. 436, 527-536. (doi:10.1042/BJ20102162)
58. Ziv Y, Bar-Shira A, Pecker I, Russell P, Jorgensen TJ, Tsarfati I, Shiloh Y. 1997 Recombinant ATM protein complements the cellular A-T phenotype. Oncogene 15, 159-167. (doi:10.1038/sj.onc.1201319)
59. Shiloh Y. 2014 ATM: expanding roles as a chief guardian of genome stability. Exp. Cell Res. 329, 154-161. (doi:10.1016/j.yexcr.2014.09.002)
60. O'Driscoll M, Ruiz-Perez VL, Woods CG, Jeggo PA, Goodship JA. 2003 A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 33, 497-501. (doi:10.1038/ng1129)
61. O'Driscoll M, Gennery AR, Seidel J, Concannon P, Jeggo PA. 2004 An overview of three new disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome. DNA Repair 3, 1227-1235. (doi:10.1016/j.dnarep.2004.03.025)
62. Finnie N, Gottlieb T. 1995 DNA-dependent protein kinase activity is absent in xrs-6 cells: Implications for site-specific recombination and DNA doublestrand break repair. Proc. Natl Acad. Sci. USA 92, 320-324. (doi:10.1073/pnas.92.1.320)
63. Blunt T et al. 1995 Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 80, 813-823. (doi:10.1016/0092-8674(95)90360-7)
64. Kurimasa A, Kumano S. 1999 Requirement for the kinase activity of human DNA-dependent protein kinase catalytic subunit in DNA strand break rejoining. Mol. Cell. Biol. 19, 3877.
65. Van der Burg M et al. 2009 A DNA-PKcs mutation in a radiosensitive T - B- SCID patient inhibits Artemis activation and nonhomologous end-joining. J. Clin. Invest. 119, 91-98. (doi:10.1172/JCI37141)
66. Rogakou E, Pilch D, Orr A, Ivanova V, Bonner W. 1998 DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273, 5858-5868. (doi:10.1074/jbc.273.10.5858)
67. Stiff T, Driscoll MO, Rief N, Iwabuchi K, Lo M, Jeggo PA. 2004 ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res. 64, 2390-2396. (doi:10.1158/0008-5472.CAN-03-3207)
68. Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP. 2005 MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 123, 1213-1226. (doi:10.1016/j.cell.2005.09.038)
69. Stracker TH, Usui T, Petrini JHJ. 2009 Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response. DNA Repair 8, 1047-1054. (doi:10.1016/j.dnarep.2009.04.012)
70. Bartek J, Lukas J. 2003 Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3, 421-429. (doi:10.1016/S1535-6108(03)00110-7)
71. Reinhardt H, Yaffe M. 2009 Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr. Opin. Cell Biol. 21, 245-255. (doi:10.1016/j.ceb.2009.01.018)
72. Hirao A et al. 2002 Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATMindependent manner. Mol. Cell. Biol. 22, 6521-6532. (doi:10.1128/MCB.22.18.6521-6532.2002)
73. Takai H et al. 2002 Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J. 21, 5195-5205. (doi:10.1093/emboj/cdf506)
74. Manke IA, Nguyen A, Lim D, Stewart MQ, Elia AEH, Yaffe MB. 2005 MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol. Cell 17, 37-48. (doi:10.1016/j.molcel.2004.11.021)
75. Reinhardt HC, Aslanian AS, Lees JA, Yaffe MB. 2007 p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 11, 175-189. (doi:10.1016/j.ccr.2006.11.024)
76. Blasius M, Wagner S. 2014 A quantitative 14-3-3 interaction screen connects the nuclear exosome targeting complex to the DNA damage response. Genes Dev. 28, 1977-1982. (doi:10.1101/gad.246272.114)
77. Deriano L, Roth DB. 2013 Modernizing the nonhomologous end-joining repertoire: alternative and classical NHEJ share the stage. Annu. Rev. Genet. 47, 433-455. (doi:10.1146/annurev-genet-110711-155540)
78. Yan CT et al. 2007 IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 449, 478-482. (doi:10.1038/nature06020)
79. Frit P, Barboule N, Yuan Y, Gomez D, Calsou P. 2014 Alternative end-joining pathway(s): bricolage at DNA breaks. DNA Repair 17, 81-97. (doi:10.1016/j.dnarep.2014.02.007)
80. Park J-Y, Zhang F, Andreassen PR. 2014 PALB2: the hub of a network of tumor suppressors involved in DNA damage responses. Biochim. Biophys. Acta 1846, 263-275. (doi:10.1016/j.bbcan.2014.06.003)
81. Farmer H et al. 2005 Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917-921. (doi:10.1038/nature03445)
82. Bryant HE et al. 2005 Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADPribose) polymerase. Nature 434, 913-917. (doi:10.1038/nature03443)
83. Fong P et al. 2009 Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N. Engl. J. Med. 361, 123-134. (doi:10.1056/NEJMoa0900212)
84. Helleday T. 2011 The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings. Mol. Oncol. 5, 387-393. (doi:10.1016/j.molonc.2011.07.001)
85. Jiricny J. 2006 The multifaceted mismatch-repair system. Nat. Rev. Mol. Cell Biol. 7, 335-346. (doi:10.1038/nrm1907)
86. Caldecott KW. 2008 Single-strand break repair and genetic disease. Nat. Rev. Genet. 9, 619-631. (doi:10.1038/nrg2380)
87. Dianov GL, Hu?bscher U. 2013 Mammalian base excision repair: the forgotten archangel. Nucleic Acids Res. 41, 3483-3490. (doi:10.1093/nar/gkt076)
88. Fousteri M, Mullenders LHF. 2008 Transcriptioncoupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects. Cell Res. 18, 73-84. (doi:10.1038/cr.2008.6)
89. Sale JE. 2012 Competition, collaboration and coordination-determining how cells bypass DNA damage. J. Cell Sci. 125, 1633-1643. (doi:10.1242/jcs.094748)
90. Deans AJ, West SC. 2011 DNA interstrand crosslink repair and cancer. Nat. Rev. Cancer 11, 467-480. (doi:10.1038/nrc3088)
91. Ciehanover A, Hod Y, Hershko A. 1978 A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. Biochem. Biophys. Res. 81, 1100-1105. (doi:10.1016/0006-291X(78)91249-4)
92. Hershko A, Ciechanover A. 1980 Proposed role of ATP in protein breakdown: conjugation of protein with multiple chains of the polypeptide of ATP-dependent proteolysis. Proc. Natl Acad. Sci. USA 77, 1783-1786. (doi:10.1073/pnas.77.4.1783)
93. Wilkinson K, Urban M, Haas A. 1980 Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes. J. Biol. Chem. 1, 7529-7532.
94. Ozkaynak E, Finley D. 1987 The yeast ubiquitin genes: a family of natural gene fusions. EMBO J. 6, 1429-1439.
95. Baker RT, Board PG. 1987 The human ubiquitin gene family: structure of a gene and pseudogenes from the Ub B subfamily. Nucleic Acids Res. 15, 443-463. (doi:10.1093/nar/15.2.443)
96. Wiborg O, Pedersen M, Wind A. 1985 The human ubiquitin multigene family: some genes contain multiple directly repeated ubiquitin coding sequences. EMBO J. 4, 755-759.
97. Hershkos A, Heller H, Elias S, Ciechanover A. 1983 Components of ubiquitin-protein ligase system resolution, affinity purification. J. Biol. Chem. 258, 8206-8214.
98. Ciechanover A, Elias S, Heller H, Hershko A. 1982 'Covalent affinity' purification of ubiquitin-activating enzyme. J. Biol. Chem. 257, 2537-2542.
99. Pickart CM, Kasperek EM, Beal R, Kim A. 1994 Substrate properties of site-specific mutant ubiquitin protein (G76A) reveal unexpected mechanistic features of ubiquitin-activating enzyme (E1). J. Biol. Chem. 269, 7115-7123.
100. Schulman BA, Harper JW. 2009 Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat. Rev. Mol. Cell Biol. 10, 319-331. (doi:10.1038/nrm2673)
101. Van Wijk SJL, Timmers HTM. 2010 The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins. FASEB J. 24, 981-993. (doi:10.1096/fj.09-136259)
102. Berndsen CE, Wolberger C. 2014 New insights into ubiquitin E3 ligase mechanism. Nat. Struct. Mol. Biol. 21, 301-307. (doi:10.1038/nsmb.2780)
103. Mattiroli F, Sixma TK. 2014 Lysine-targeting specificity in ubiquitin and ubiquitin-like modification pathways. Nat. Struct. Mol. Biol. 21, 308-316. (doi:10.1038/nsmb.2792)
104. Deshaies RJ, Joazeiro CAP. 2009 RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399-434. (doi:10.1146/annurev.biochem.78. 101807.093809)
105. Plechanovová A, Jaffray EG, Tatham MH, Naismith JH, Hay RT. 2012 Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis. Nature 489, 115-120. (doi:10.1038/nature11376)
106. Koegl M, Hoppe T, Schlenker S, Ulrich HD, Mayer TU, Jentsch S. 1999 A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 96, 635-644. (doi:10.1016/S0092-8674(00) 80574-7)
107. Hatakeyama S, Yada M, Matsumoto M, Ishida N, Nakayama KI. 2001 U box proteins as a new family of ubiquitin-protein ligases. J. Biol. Chem. 276, 33 111-33 120. (doi:10.1074/jbc.M102755200)
108. Komander D, Clague MJ, Urbé S. 2009 Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 10, 550-563. (doi:10.1038/nrm2731)
109. Turcu F, Ventii K, Wilkinson K. 2009 Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu. Rev. Biochem. 78, 363-397. (doi:10.1146/annurev.biochem.78.082307.091526)
110. Mukhopadhyay D, Riezman H. 2007 Proteasomeindependent functions of ubiquitin in endocytosis and signaling. Science 315, 201-205. (doi:10.1126/science.1127085)
111. Bienko M et al. 2005 Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis. Science 310, 1821-1824. (doi:10.1126/science. 1120615)
112. Kirisako T et al. 2006 A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 25, 4877-4887. (doi:10.1038/sj.emboj.7601360)
113. Rieser E, Cordier SM, Walczak H. 2013 Linear ubiquitination: a newly discovered regulator of cell signalling. Trends Biochem. Sci. 38, 94-102. (doi:10.1016/j.tibs.2012.11.007)
114. Hershko A, Ciechanover A. 1998 The ubiquitin system. Annu. Rev. Biochem. 67, 425-479. (doi:10.1146/annurev.biochem.67.1.425)
115. Xu P et al. 2009 Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 137, 133-145. (doi:10.1016/j.cell.2009.01.041)
116. Hurley JH, Lee S, Prag G. 2006 Ubiquitin-binding domains. Biochem. J. 399, 361-372. (doi:10.1042/BJ20061138)
117. Husnjak K, Dikic I. 2012 Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu. Rev. Biochem. 81, 291-322. (doi:10.1146/annurev-biochem-051810-094654)
118. Komander D. 2009 The emerging complexity of protein ubiquitination. Biochem. Soc. Trans. 37, 937-953. (doi:10.1042/BST0370937)
119. Komander D, Rape M. 2012 The ubiquitin code. Annu. Rev. Biochem. 81, 203-229. (doi:10.1146/annurev-biochem-060310-170328)
120. Hochstrasser M. 2009 Origin and function of ubiquitin-like proteins. Nature 458, 422-429. (doi:10.1038/nature07958)
121. Van der Veen AG, Ploegh HL. 2012 Ubiquitin-like proteins. Annu. Rev. Biochem. 81, 323-357. (doi:10.1146/annurev-biochem-093010-153308)
122. Jentsch S, McGrath J, Varshavsky A. 1986 The yeast DNA repair gene RAD6 encodes a ubiquitinconjugating enzyme. Nature 329, 131-134. (doi:10.1038/329131a0)
123. Hoege C, Pfander B, Moldovan G-L, Pyrowolakis G, Jentsch S. 2002 RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419, 135-141. (doi:10.1038/nature00991)
124. Kannouche PL, Wing J, Lehmann AR. 2004 Interaction of human DNA polymerase h with monoubiquitinated PCNA. Mol. Cell 14, 491-500. (doi:10.1016/S1097-2765(04)00259-X)
125. Watanabe K, Tateishi S, Kawasuji M, Tsurimoto T, Inoue H, Yamaizumi M. 2004 Rad18 guides poleta to replication stalling sites through physical interaction and PCNA monoubiquitination. EMBO J. 23, 3886-3896. (doi:10.1038/sj.emboj.7600383)
126. Simpson LJ, Ross A-L, Szu?ts D, Alviani CA, Oestergaard VH, Patel KJ, Sale JE. 2006 RAD18-independent ubiquitination of proliferating-cell nuclear antigen in the avian cell line DT40. EMBO Rep. 7, 927-932. (doi:10.1038/sj.embor.7400777)
127. Stewart GS et al. 2009 The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell 136, 420-434. (doi:10.1016/j.cell.2008.12.042)
128. Doil C et al. 2009 RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell 136, 435-446. (doi:10.1016/j.cell.2008.12.041)
129. Kolas NK et al. 2007 Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science 318, 1637-1640. (doi:10.1126/science.1150034)
130. Huen MSY, Grant R, Manke I, Minn K, Yu X, Yaffe MB, Chen J. 2007 RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell 131, 901-914. (doi:10.1016/j.cell.2007.09.041)
131. Mailand N, Bekker-Jensen S, Faustrup H, Melander F, Bartek J, Lukas C, Lukas J. 2007 RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 131, 887-900. (doi:10.1016/j.cell.2007.09.040)
132. Bekker-Jensen S, Danielsen JR, Fugger K, Gromova I, Nerstedt A, Lukas C, Bartek J, Lukas J, Mailand N. 2010 HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes. Nat. Cell Biol. 12, 80-86. (doi:10.1038/ncb2008)
133. Oestergaard VH, Pentzold C, Pedersen RT, Iosif S, Alpi A, Bekker-Jensen S, Mailand N, Lisby M. 2012 RNF8 and RNF168 but not HERC2 are required for DNA damage-induced ubiquitylation in chicken DT40 cells. DNA Repair 11, 892-905. (doi:10.1016/j.dnarep.2012.08.005)
134. Pinato S, Gatti M, Scandiuzzi C, Confalonieri S, Penengo L. 2011 UMI, a novel RNF168 ubiquitin binding domain involved in the DNA damage signaling pathway. Mol. Cell. Biol. 31, 118-126. (doi:10.1128/MCB.00818-10)
135. Mattiroli F, Vissers JHA, van Dijk WJ, Ikpa P, Citterio E, Vermeulen W, Marteijn JA, Sixma TK. 2012 RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling. Cell 150, 1182-1195. (doi:10.1016/j.cell.2012.08.005)
136. Mattiroli F, Uckelmann M, Sahtoe DD, van Dijk WJ, Sixma TK. 2014 The nucleosome acidic patch plays a critical role in RNF168-dependent ubiquitination of histone H2A. Nat. Commun. 5, 3291. (doi:10.1038/ncomms4291)
137. Panier S, Ichijima Y, Fradet-Turcotte A, Leung CCY, Kaustov L, Arrowsmith CH, Durocher D. 2012 Tandem protein interaction modules organize the ubiquitin-dependent response to DNA double-strand breaks. Mol. Cell 47, 383-395. (doi:10.1016/j.molcel.2012.05.045)
138. Stewart GS et al. 2007 RIDDLE immunodeficiency syndrome is linked to defects in 53BP1-mediated DNA damage signaling. Proc. Natl Acad. Sci. USA 104, 16 910-16 915. (doi:10.1073/pnas. 0708408104)
139. Kracker S, Durandy A. 2011 Insights into the B cell specific process of immunoglobulin class switch recombination. Immunol. Lett. 138, 97-103. (doi:10.1016/j.imlet.2011.02.004)
140. Rai R, Li J, Zheng H, Lok G. 2011 The E3 ubiquitin ligase RNF8 stabilizes TPP1 to promote telomere end protection. Nat. Struct. 18, 1400-1407. (doi:10.1038/nsmb.2172)
141. Peuscher MH, Jacobs JJL. 2011 DNA-damage response and repair activities at uncapped telomeres depend on RNF8. Nat. Cell Biol. 13, 1139-1145. (doi:10.1038/ncb2326)
142. Shanbhag NM, Rafalska-Metcalf IU, Balane-Bolivar C, Janicki SM, Greenberg RA. 2010 ATM-dependent chromatin changes silence transcription in cis to DNA double-strand breaks. Cell 141, 970-981. (doi:10.1016/j.cell.2010.04.038)
143. Giunta S, Belotserkovskaya R, Jackson SP. 2010 DNA damage signaling in response to double-strand breaks during mitosis. J. Cell Biol. 190, 197-207. (doi:10.1083/jcb.200911156)
144. Orthwein A, Fradet-Turcotte A, Noordermeer SM, Canny MD, Brun CM, Strecker J, Escribano-Diaz C, Durocher D. 2014 Mitosis inhibits DNA doublestrand break repair to guard against telomere fusions. Science 344, 189-193. (doi:10.1126/science.1248024)
145. Noon AT, Goodarzi AA. 2011 53BP1-mediated DNA double strand break repair: insert bad pun here. DNA Repair 10, 1071-1076. (doi:10.1016/j.dnarep.2011.07.012)
146. Li M, Greenberg R. 2012 Links between genome integrity and BRCA1 tumor suppression. Trends Biochem. Sci. 37, 418-424. (doi:10.1016/j.tibs.2012.06.007)
147. Huyen Y, Zgheib O. 2004 Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature 432, 406-411. (doi:10.1038/nature03114)
148. Fradet-Turcotte A et al. 2013 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark. Nature 499, 50-54. (doi:10.1038/nature12318)
149. Hu Y, Scully R, Sobhian B, Xie A, Shestakova E, Livingston DM. 2011 RAP80-directed tuning of BRCA1 homologous recombination function at ionizing radiation-induced nuclear foci. Genes Dev. 25, 685-700. (doi:10.1101/gad.2011011)
150. Bekker-Jensen S, Lukas C, Kitagawa R, Melander F, Kastan MB, Bartek J, Lukas J. 2006 Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J. Cell Biol. 173, 195-206. (doi:10.1083/jcb.200510130)
151. Guzzo CM, Berndsen CE, Zhu J, Gupta V, Datta A, Greenberg RA, Wolberger C, Matunis MJ. 2012 RNF4-dependent hybrid SUMO-ubiquitin chains are signals for RAP80 and thereby mediate the recruitment of BRCA1 to sites of DNA damage. Sci. Signal. 5, ra88. (doi:10.1126/scisignal.2003485)
152. Hu X, Paul A, Wang B. 2012 Rap80 protein recruitment to DNA double-strand breaks requires binding to both small ubiquitin-like modifier (SUMO) and ubiquitin conjugates. J. Biol. Chem. 287, 25 510-25 519. (doi:10.1074/jbc.M112.374116)
153. Huen MSY, Sy SMH, Chen J. 2010 BRCA1 and its toolbox for the maintenance of genome integrity. Nat. Rev. Mol. Cell Biol. 11, 138-148. (doi:10.1038/nrm2831)
154. Reid LJ, Shakya R, Modi AP, Lokshin M, Cheng J-T, Jasin M, Baer R, Ludwig T. 2008 E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks. Proc. Natl Acad. Sci. USA 105, 20 876-20 881. (doi:10.1073/pnas.0811203106)
155. Shakya R et al. 2011 BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity. Science 334, 525-528. (doi:10.1126/science.1209909)
156. Drost R et al. 2011 BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance. Cancer Cell 20, 797-809. (doi:10.1016/j.ccr.2011.11.014)
157. Bunting SF et al. 2010 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 141, 243-254. (doi:10.1016/j.cell.2010.03.012)
158. Chapman JR et al. 2013 RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection. Mol. Cell 49, 858-871. (doi:10.1016/j.molcel.2013. 01.002)
159. Escribano-Díaz C et al. 2013 A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. Mol. Cell 49, 872-883. (doi:10.1016/j.molcel.2013.01.001)
160. Jacq X, Kemp M, Martin NMB, Jackson SP. 2013 Deubiquitylating enzymes and DNA damage response pathways. Cell Biochem. Biophys. 67, 25-43. (doi:10.1007/s12013-013-9635-3)
161. Poulsen M, Lukas C, Lukas J, Bekker-Jensen S, Mailand N. 2012 Human RNF169 is a negative regulator of the ubiquitin-dependent response to DNA double-strand breaks. J. Cell Biol. 197, 189-199. (doi:10.1083/jcb.201109100)
162. Chen J, Feng W, Jiang J, Deng Y, Huen MSY. 2012 Ring finger protein RNF169 antagonizes the ubiquitin-dependent signaling cascade at sites of DNA damage. J. Biol. Chem. 287, 27 715-27 722. (doi:10.1074/jbc.M112.373530)
163. Gudjonsson T et al. 2012 TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes. Cell 150, 697-709. (doi:10.1016/j.cell.2012.06.039)
164. Nakamura K et al. 2011 Regulation of homologous recombination by RNF20-dependent H2B ubiquitination. Mol. Cell 41, 515-528. (doi:10.1016/j.molcel.2011.02.002)
165. Moyal L et al. 2011 Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Mol. Cell 41, 529-542. (doi:10.1016/j.molcel.2011.02.015)
166. Meetei AR et al. 2003 A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35, 165-170. (doi:10.1038/ng1241)
167. Machida YJ, Machida Y, Chen Y, Gurtan AM, Kupfer GM, D'Andrea AD, Dutta A. 2006 UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol. Cell 23, 589-596. (doi:10.1016/j.molcel.2006.06.024)
168. MacKay C et al. 2010 Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2. Cell 142, 65-76. (doi:10.1016/j.cell.2010.06.021)
169. Kratz K et al. 2010 Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents. Cell 142, 77-88. (doi:10.1016/j.cell.2010.06.022)
170. Smogorzewska A et al. 2010 A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol. Cell 39, 36-47. (doi:10.1016/j.molcel.2010.06.023)
171. Murina O, von Aesch C, Karakus U, Ferretti LP, Bolck HA, Hänggi K, Sartori AA. 2014 FANCD2 and CtIP cooperate to repair DNA interstrand crosslinks. Cell Rep. 7, 1030-1038. (doi:10.1016/j.celrep.2014. 03.069)
172. Zhang N, Kaur R, Akhter S, Legerski RJ. 2009 Cdc5L interacts with ATR and is required for the S-phase cell-cycle checkpoint. EMBO Rep. 10, 1029-1035. (doi:10.1038/embor.2009.122)
173. Marechal A et al. 2014 PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry. Mol. Cell 53, 235-246. (doi:10.1016/j.molcel.2013.11.002)
174. Wan L, Huang J. 2014 The PSO4 protein complex associates with replication protein A (RPA) and modulates the activation of ataxia telangiectasiamutated and RAD3-related (ATR). J. Biol. Chem. 289, 6619-6626. (doi:10.1074/jbc.M113.543439)
175. Gong Z, Chen J. 2011 E3 ligase RFWD3 participates in replication checkpoint control. J. Biol. Chem. 286, 22 308-22 313. (doi:10.1074/jbc.M111.222869)
176. Liu S, Chu J, Yucer N, Leng M, Wang SY, Chen BPC, Hittelman WN, Wang Y. 2011 RING finger and WD repeat domain 3 (RFWD3) associates with replication protein A (RPA) and facilitates RPAmediated DNA damage response. J. Biol. Chem. 286, 22 314-22 322. (doi:10.1074/jbc.M111.222802)
177. Fu X et al. 2010 RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage. Proc. Natl Acad. Sci. USA 107, 4579-4584. (doi:10.1073/pnas.0912094107)
178. Chan S-P, Kao D-I, Tsai W-Y, Cheng S-C. 2003 The Prp19p-associated complex in spliceosome activation. Science 302, 279-282. (doi:10.1126/science.1086602)
179. Prudden J, Pebernard S, Raffa G, Slavin DA, Perry JJP, Tainer JA, McGowan CH, Boddy MN. 2007 SUMO-targeted ubiquitin ligases in genome stability. EMBO J. 26, 4089-4101. (doi:10.1038/sj. emboj.7601838)
180. Yin Y, Seifert A, Chua JS, Maure J-F, Golebiowski F, Hay RT. 2012 SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage. Genes Dev. 26, 1196-1208. (doi:10.1101/gad.189274.112)
181. Galanty Y, Belotserkovskaya R, Coates J, Jackson SP. 2012 RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair. Genes Dev. 26, 1179-1195. (doi:10.1101/gad.188284.112)
182. Gibbs-Seymour I et al. 2015 Ubiquitin-SUMO circuitry controls activated Fanconi anemia ID complex dosage in response to DNA damage. Mol. Cell 57, 150-164. (doi:10.1016/j.molcel.2014.12.001)
183. Rojas-Fernandez A, Plechanovová A, Hattersley N, Jaffray E, Tatham MH, Hay RT. 2014 SUMO chaininduced dimerization activates RNF4. Mol. Cell 53, 880-892. (doi:10.1016/j.molcel.2014.02.031)
184. Poulsen SL et al. 2013 RNF111/Arkadia is a SUMOtargeted ubiquitin ligase that facilitates the DNA damage response. J. Cell Biol. 201, 797-807. (doi:10.1083/jcb.201212075)
185. Finley D. 2009 Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 78, 477-513. (doi:10.1146/annurev.biochem.78.081507.101607)
186. Butler LR et al. 2012 The proteasomal deubiquitinating enzyme POH1 promotes the double-strand DNA break response. EMBO J. 31, 3918-3934. (doi:10.1038/emboj.2012.232)
187. Molinari M, Mercurio C, Dominguez J, Goubin F, Draetta GF. 2000 Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep. 1, 71-79. (doi:10.1093/embo-reports/kvd018)
188. Wu W, Sato K, Koike A, Nishikawa H, Koizumi H, Venkitaraman AR, Ohta T. 2010 HERC2 is an E3 ligase that targets BRCA1 for degradation. Cancer Res. 70, 6384-6392. (doi:10.1158/0008-5472.CAN-10-1304)
189. Shi W, Ma Z, Willers H, Akhtar K, Scott SP, Zhang J, Powell S, Zhang J. 2008 Disassembly of MDC1 foci is controlled by ubiquitin-proteasome-dependent degradation. J. Biol. Chem. 283, 31 608-31 616. (doi:10.1074/jbc.M801082200)
190. Meyer H, Bug M, Bremer S. 2012 Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat. Cell Biol. 14, 117-123. (doi:10.1038/ncb2407)
191. Dantuma NP, Acs K, Luijsterburg MS. 2014 Should I stay or should I go: VCP/p97-mediated chromatin extraction in the DNA damage response. Exp. Cell Res 329, 9-17. (doi:10.1016/j.yexcr.2014.08.025)
192. Puumalainen M-R, Lessel D, Rüthemann P, Kaczmarek N, Bachmann K, Ramadan K, Naegeli H. 2014 Chromatin retention of DNA damage sensors DDB2 and XPC through loss of p97 segregase causes genotoxicity. Nat. Commun. 5, 3695. (doi:10.1038/ncomms4695)
193. Raman M, Havens CG, Walter JC, Harper JW. 2011 A genome-wide screen identifies p97 as an essential regulator of DNA damage-dependent CDT1 destruction. Mol. Cell 44, 72-84. (doi:10.1016/j.molcel.2011.06.036)
194. Meerang M et al. 2011 The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks. Nat. Cell Biol. 13, 1376-1382. (doi:10.1038/ncb2367)
195. Davis EJ, Lachaud C, Appleton P, Macartney TJ, Näthke I, Rouse J. 2012 DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA damage. Nat. Struct. Mol. Biol. 19, 1093-1100. (doi:10.1038/nsmb.2394)
196. Mosbech A et al. 2012 DVC1 (C1orf124) is a DNA damage-targeting p97 adaptor that promotes ubiquitin-dependent responses to replication blocks. Nat. Struct. Mol. Biol. 19, 1084-1092. (doi:10.1038/nsmb.2395)
197. Maskey RS, Kim MS, Baker DJ, Childs B, Malureanu LA, Jeganathan KB, Machida Y, van Deursen JM, Machida YJ. 2014 Spartan deficiency causes genomic instability and progeroid phenotypes. Nat. Commun. 5, 5744. (doi:10.1038/ncomms6744)
198. Lessel D et al. 2014 Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features. Nat. Genet. 46, 1239-1244. (doi:10.1038/ng.3103)
199. Nie M, Aslanian A, Prudden J, Heideker J, Vashisht AA, Wohlschlegel JA, Yates JR, Boddy MN. 2012 Dual recruitment of Cdc48 ( p97)-Ufd1-Npl4 ubiquitin-selective segregase by small ubiquitin-like modifier protein (SUMO) and ubiquitin in SUMOtargeted ubiquitin ligase-mediated genome stability functions. J. Biol. Chem. 287, 29 610-29 619. (doi:10.1074/jbc.M112.379768)
200. Bergink S, Ammon T, Kern M, Schermelleh L, Leonhardt H, Jentsch S. 2013 Role of Cdc48/p97 as a SUMO-targeted segregase curbing Rad51-Rad52 interaction. Nat. Cell Biol. 15, 526-532. (doi:10.1038/ncb2729)
201. Sun X-X, Challagundla KB, Dai M-S. 2011 Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1. EMBO J. 31, 576-592. (doi:10.1038/emboj.2011.434)
202. Nakada S et al. 2010 Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1. Nature 466, 941-946. (doi:10.1038/nature09297)
203. Juang Y-C et al. 2012 OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function. Mol. Cell 45, 384-397. (doi:10.1016/j.molcel.2012.01.011)
204. Wiener R, Zhang X, Wang T, Wolberger C. 2012 The mechanism of OTUB1-mediated inhibition of ubiquitination. Nature 483, 618-622. (doi:10.1038/nature10911)
205. Mosbech A, Lukas C, Bekker-Jensen S, Mailand N. 2013 The deubiquitylating enzyme USP44 counteracts the DNA double-strand break response mediated by the RNF8 and RNF168 ubiquitin ligases. J. Biol. Chem. 288, 16 579-16 587. (doi:10.1074/jbc.M113.459917)
206. Zhang Y, Foreman O, Wigle DA, Kosari F, Vasmatzis G, Salisbury JL, van Deursen J, Galardy PJ. 2012 USP44 regulates centrosome positioning to prevent aneuploidy and suppress tumorigenesis. J. Clin. Invest. 122, 4362-4374. (doi:10.1172/JCI63084)
207. Stegmeier F et al. 2007 Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature 446, 876-881. (doi:10.1038/nature05694)
208. Nijman SMB, Huang TT, Dirac AMG, Brummelkamp TR, Kerkhoven RM, D'Andrea AD, Bernards R. 2005 The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 17, 331-339. (doi:10.1016/j.molcel.2005.01.008)
209. Oestergaard VH et al. 2007 Deubiquitination of FANCD2 is required for DNA crosslink repair. Mol. Cell 28, 798-809. (doi:10.1016/j.molcel.2007.09.020)
210. Zhang D, Zaugg K, Mak TW, Elledge SJ. 2006 A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. Cell 126, 529-542. (doi:10.1016/j.cell.2006.06.039)
211. Knobel PA, Belotserkovskaya R, Galanty Y, Schmidt CK, Jackson SP, Stracker TH. 2014 USP28 is recruited to sites of DNA damage by the tandem BRCT domains of 53BP1 but plays a minor role in doublestrand break metabolism. Mol. Cell. Biol. 34, 2062-2074. (doi:10.1128/MCB.00197-14)
212. Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G. 2013 BAP1 and cancer. Nat. Rev. Cancer 13, 153-159. (doi:10.1038/nrc3459)
213. Ismail IH, Davidson R, Gagné JP, Xu ZZ, Poirier GG, Hendzel MJ. 2014 Germline mutations in BAP1 impair its function in DNA double-strand break repair. Cancer Res. 74, 4282-4294. (doi:10.1158/0008-5472.CAN-13-3109)
214. Yu H et al. 2014 Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair. Proc. Natl Acad. Sci. USA 111, 285-290. (doi:10.1073/pnas.1309085110)
215. Nishi R, Wijnhoven P, le Sage C, Tjeertes J, Galanty Y, Forment JV, Clague MJ, Urbé S, Jackson SP. 2014 Systematic characterization of deubiquitylating enzymes for roles in maintaining genome integrity. Nat. Cell Biol. 16, 1016-1026. (doi:10.1038/ncb3028)
216. Kumar S, Tomooka Y, Noda M. 1992 Identification of a set of genes with developmentally downregulated expression in the mouse brain. Biochem. Biophys. Res. 185, 1155-1161. (doi:10.1016/0006-291X(92)91747-E)
217. Kamitani T, Kito K, Nguyen HP, Yeh ETH. 1997 Characterization of NEDD8, a developmentally down-regulated ubiquitin-like protein. J. Biol. Chem. 272, 28 557-28 562. (doi:10.1074/jbc. 272.45.28557)
218. Whitby FG, Xia G, Pickart CM, Hill CP. 1998 Crystal structure of the human ubiquitin-like protein NEDD8 and interactions with ubiquitin pathway enzymes. J. Biol. Chem. 273, 34 983-34 991. (doi:10.1074/jbc.273.52.34983)
219. Liakopoulos D, Doenges G, Matuschewski K, Jentsch S. 1998 A novel protein modification pathway related to the ubiquitin system. EMBO J. 17, 2208-2214. (doi:10.1093/emboj/17.8.2208)
220. Lammer D, Mathias N, Laplaza JM, Jiang W, Liu Y, Callis J, Goebl M, Estelle M. 1998 Modification of yeast Cdc53p by the ubiquitin-related protein Rub1p affects function of the SCFCdc4 complex. Genes Dev. 12, 914-926. (doi:10.1101/gad. 12.7.914)
221. Mendoza HM, Shen L-N, Botting C, Lewis A, Chen J, Ink B, Hay RT. 2003 NEDP1, a highly conserved cysteine protease that deNEDDylates cullins. J. Biol. Chem. 278, 25 637-25 643. (doi:10.1074/jbc.M212948200)
222. Wada H, Kito K, Caskey LS, Yeh ET, Kamitani T. 1998 Cleavage of the C-terminus of NEDD8 by UCH-L3. Biochem. Biophys. Res. Commun. 251, 688-692. (doi:10.1006/bbrc.1998.9532)
223. Burch TJ, Haas AL. 1994 Site-directed mutagenesis of ubiquitin. Differential roles for arginine in the interaction with ubiquitin-activating enzyme. Biochemistry 33, 7300-7308. (doi:10.1021/bi00189a035)
224. Souphron J, Waddell MB, Paydar A, Tokgöz-Gromley Z, Roussel MF, Schulman BA. 2008 Structural dissection of a gating mechanism preventing misactivation of ubiquitin by NEDD80s E1. Biochemistry 47, 8961-8969. (doi:10.1021/bi800604c)
225. Walden H, Podgorski MS, Huang DT, Miller DW, Howard RJ, Minor DL, Holton JM, Schulman BA. 2003 The structure of the APPBP1-UBA3-NEDD8-ATP complex reveals the basis for selective ubiquitin-like protein activation by an E1. Mol. Cell 12, 1427-1437. (doi:10.1016/S1097-2765(03)00452-0)
226. Bohnsack RN, Haas AL. 2003 Conservation in the mechanism of Nedd8 activation by the human AppBp1-Uba3 heterodimer. J. Biol. Chem. 278, 26 823-26 830. (doi:10.1074/jbc.M303177200)
227. Huang DT, Paydar A, Zhuang M, Waddell MB, Holton JM, Schulman BA. 2005 Structural basis for recruitment of Ubc12 by an E2 binding domain in NEDD80s E1. Mol. Cell 17, 341-350. (doi:10.1016/j.molcel.2004.12.020)
228. Leidecker O, Matic I, Mahata B, Pion E, Xirodimas DP. 2012 The ubiquitin E1 enzyme Ube1 mediates NEDD8 activation under diverse stress conditions. Cell Cycle 11, 1142-1150. (doi:10.4161/cc.11.6.19559)
229. Hjerpe R, Thomas Y, Chen J, Zemla A, Curran S, Shpiro N, Dick LR, Kurz T. 2012 Changes in the ratio of free NEDD8 to ubiquitin triggers NEDDylation by ubiquitin enzymes. Biochem. J. 441, 927-936. (doi:10.1042/BJ20111671)
230. Gong L, Yeh ETH. 1999 Identification of the activating and conjugating enzymes of the NEDD8 conjugation pathway. J. Biol. Chem. 274, 12 036-12 042. (doi:10.1074/jbc.274.17.12036)
231. Osaka F, Kawasaki H, Aida N, Saeki M, Chiba T, Kawashima S, Tanaka K, Kato S. 1998 A new NEDD8-ligating system for cullin-4A. Genes Dev. 12, 2263-2268. (doi:10.1101/gad.12.15.2263)
232. Huang DT et al. 2009 E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification. Mol. Cell 33, 483-495. (doi:10.1016/j.molcel.2009.01.011)
233. Scott DC, Monda JK, Grace CRR, Duda DM, Kriwacki RW, Kurz T, Schulman BA. 2010 A dual E3 mechanism for Rub1 ligation to Cdc53. Mol. Cell 39, 784-796. (doi:10.1016/j.molcel.2010.08.030)
234. Kamura T, Conrad MN, Yan Q, Conaway RC, Conaway JW. 1999 The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2. Genes Dev. 13, 2928-2933. (doi:10.1101/gad.13.22.2928)
235. Petroski MD, Deshaies RJ. 2005 Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 6, 9-20. (doi:10.1038/nrm1547)
236. Kurz T, Ozlü N, Rudolf F, O'Rourke SM, Luke B, Hofmann K, Hyman AA, Bowerman B, Peter M. 2005 The conserved protein DCN-1/Dcn1p is required for cullin neddylation in C. elegans and S. cerevisiae. Nature 435, 1257-1261. (doi:10.1038/nature03662)
237. Kim AY et al. 2008 SCCRO (DCUN1D1) is an essential component of the E3 complex for neddylation. J. Biol. Chem. 283, 33 211-33 220. (doi:10.1074/jbc.M804440200)
238. Kurz T, Chou Y-C, Willems AR, Meyer-Schaller N, Hecht M-L, Tyers M, Peter M, Sicheri F. 2008 Dcn1 functions as a scaffold-type E3 ligase for cullin neddylation. Mol. Cell 29, 23-35. (doi:10.1016/j.molcel.2007.12.012)
239. Meyer-Schaller N et al. 2009 The human Dcn1-like protein DCNL3 promotes Cul3 neddylation at membranes. Proc. Natl Acad. Sci. USA 106, 12 365-12 370. (doi:10.1073/pnas.0812528106)
240. Monda JK, Scott DC, Miller DJ, Lydeard J, King D, Harper JW, Bennett EJ, Schulman BA. 2013 Structural conservation of distinctive N-terminal acetylation-dependent interactions across a family of mammalian NEDD8 ligation enzymes. Structure 21, 42-53. (doi:10.1016/j.str.2012.10.013)
241. Wu K, Yan H, Fang L, Wang X, Pfleger C, Jiang X, Huang L, Pan Z-Q. 2011 Mono-ubiquitination drives nuclear export of the human DCN1-like protein hDCNL1. J. Biol. Chem. 286, 34 060-34 070. (doi:10.1074/jbc.M111.273045)
242. Girdwood D, Xirodimas DP, Gordon C. 2011 The essential functions of NEDD8 are mediated via distinct surface regions, and not by polyneddylation in Schizosaccharomyces pombe. PLoS ONE 6, e20089. (doi:10.1371/journal.pone.0020089)
243. Xirodimas DP, Sundqvist A, Nakamura A, Shen L, Botting C, Hay RT. 2008 Ribosomal proteins are targets for the NEDD8 pathway. EMBO Rep. 9, 280-286. (doi:10.1038/embor.2008.10)
244. Jones J, Wu K, Yang Y, Guerrero C. 2008 A targeted proteomic analysis of the ubiquitin-like modifier Nedd8 and associated proteins. J. Proteome 7, 1274-1287. (doi:10.1021/pr700749v)
245. Wei N, Deng XW. 1992 COP9: a new genetic locus involved in light-regulated development and gene expression in arabidopsis. Plant Cell 4, 1507-1518. (doi:10.1105/tpc.4.12.1507)
246. Cope GA, Suh GSB, Aravind L, Schwarz SE, Zipursky SL, Koonin EV, Deshaies RJ. 2002 Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1. Science 298, 608-611. (doi:10.1126/science.1075901)
247. Sharon M, Mao H, Boeri Erba E, Stephens E, Zheng N, Robinson CV. 2009 Symmetrical modularity of the COP9 signalosome complex suggests its multifunctionality. Structure 17, 31-40. (doi:10.1016/j.str.2008.10.012)
248. Lingaraju GM, Bunker RD, Cavadini S, Hess D, Hassiepen U, Renatus M, Fischer ES, Thomä NH. 2014 Crystal structure of the human COP9 signalosome. Nature 512, 161-165. (doi:10.1038/nature13566)
249. Rabut G, Peter M. 2008 Function and regulation of protein neddylation. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep. 9, 969-976. (doi:10.1038/embor.2008.183)
250. Lydeard JR, Schulman BA, Harper JW. 2013 Building and remodelling Cullin-RING E3 ubiquitin ligases. EMBO Rep. 14, 1050-1061. (doi:10.1038/embor.2013.173)
251. Sarikas A, Hartmann T, Pan Z-Q. 2011 The cullin protein family. Genome Biol. 12, 220. (doi:10.1186/gb-2011-12-4-220)
252. Soucy TA et al. 2009 An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458, 732-736. (doi:10.1038/nature07884)
253. Shibata E, Abbas T, Huang X, Wohlschlegel JA, Dutta A. 2011 Selective ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G ubiquitin-conjugating enzymes via the CRL4Cdt2 ubiquitin ligase complex. Mol. Cell. Biol. 31, 3136-3145. (doi:10.1128/MCB.05496-11)
254. Lee J, Zhou P. 2007 DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase. Mol. Cell 26, 775-780. (doi:10.1016/j.molcel.2007.06.001)
255. Bennett EJ, Rush J, Gygi SP, Harper JW. 2010 Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics. Cell 143, 951-965. (doi:10.1016/j.cell.2010.11.017)
256. Xu C, Min J. 2011 Structure and function of WD40 domain proteins. Protein Cell 2, 202-214. (doi:10.1007/s13238-011-1018-1)
257. Emanuele MJ et al. 2011 Global identification of modular cullin-RING ligase substrates. Cell 147, 459-474. (doi:10.1016/j.cell.2011.09.019)
258. Larance M, Kirkwood KJ, Xirodimas DP, Lundberg E, Uhlen M, Lamond AI. 2011 Characterization of MRFAP1 turnover and interactions downstream of the NEDD8 pathway. Mol. Cell. Proteomics 11, M111.014407. (doi:10.1074/mcp.M111.014407)
259. Duda DM, Borg LA, Scott DC, Hunt HW, Hammel M, Schulman BA. 2008 Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 134, 995-1006. (doi:10.1016/j.cell.2008.07.022)
260. Zheng J et al. 2002 CAND1 binds to unneddylated CUL1 and regulates the formation of SCF ubiquitin E3 ligase complex. Mol. Cell 10, 1519-1526. (doi:10.1016/S1097-2765(02)00784-0)
261. Liu J, Furukawa M, Matsumoto T, Xiong Y, Hill C, Carolina N. 2002 NEDD8 modification of CUL1 dissociates p120, an inhibitor of CUL1-SKP1 binding and SCF ligases. Mol. Cell 10, 1511-1518. (doi:10.1016/S1097-2765(02)00783-9)
262. Zemla A, Thomas Y, Kedziora S, Knebel A, Wood NT, Rabut G, Kurz T. 2013 CSN- and CAND1-dependent remodelling of the budding yeast SCF complex. Nat. Commun. 4, 1641. (doi:10.1038/ncomms2628)
263. Pierce NW et al. 2013 Cand1 promotes assembly of new SCF complexes through dynamic exchange of F box proteins. Cell 153, 206-215. (doi:10.1016/j.cell.2013.02.024)
264. Wu S, Zhu W, Nhan T, Toth JI, Petroski MD, Wolf DA. 2013 CAND1 controls in vivo dynamics of the cullin 1-RING ubiquitin ligase repertoire. Nat. Commun. 4, 1642. (doi:10.1038/ncomms2636)
265. Zhou C, Wee S, Rhee E, Naumann M, Dubiel W, Wolf DA. 2003 Fission yeast COP9/signalosome suppresses cullin activity through recruitment of the deubiquitylating enzyme Ubp12p. Mol. Cell 11, 927-938. (doi:10.1016/S1097-2765(03)00136-9)
266. Fischer ES et al. 2011 The molecular basis of CRL4DDB2/CSA ubiquitin ligase architecture, targeting, and activation. Cell 147, 1024-1039. (doi:10.1016/j.cell.2011.10.035)
267. Emberley ED, Mosadeghi R, Deshaies RJ. 2012 Deconjugation of Nedd8 from Cul1 is directly regulated by Skp1-F-box and substrate, and the COP9 signalosome inhibits deneddylated SCF by a noncatalytic mechanism. J. Biol. Chem. 287, 29 679-29 689. (doi:10.1074/jbc.M112.352484)
268. Enchev RI, Scott DC, da Fonseca PCA, Schreiber A, Monda JK, Schulman BA, Peter M, Morris EP. 2012 Structural basis for a reciprocal regulation between SCF and CSN. Cell Rep. 2, 616-627. (doi:10.1016/j.celrep.2012.08.019)
269. Schmidt MW, McQuary PR, Wee S, Hofmann K, Wolf DA. 2009 F-box-directed CRL complex assembly and regulation by the CSN and CAND1. Mol. Cell 35, 586-597. (doi:10.1016/j.molcel.2009.07.024)
270. Chew E-H, Hagen T. 2007 Substrate-mediated regulation of cullin neddylation. J. Biol. Chem. 282, 17 032-17 040. (doi:10.1074/jbc.M701153200)
271. Duda DM, Scott DC, Calabrese MF, Zimmerman ES, Zheng N, Schulman BA. 2011 Structural regulation of cullin-RING ubiquitin ligase complexes. Curr. Opin. Struct. Biol. 21, 257-264. (doi:10.1016/j.sbi.2011.01.003)
272. Watson IR, Irwin MS, Ohh M. 2011 NEDD8 pathways in cancer, Sine Quibus Non. Cancer Cell 19, 168-176. (doi:10.1016/j.ccr.2011.01.002)
273. Melchor L et al. 2009 Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes. Breast Cancer Res. 11, R86. (doi:10.1186/bcr2456)
274. Brownell JE et al. 2010 Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ. Mol. Cell 37, 102-111. (doi:10.1016/j.molcel.2009.12.024)
275. Lin JJ, Milhollen MA, Smith PG, Narayanan U, Dutta A. 2010 NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells. Cancer Res. 70, 10 310-10 320. (doi:10.1158/0008-5472.CAN-10-2062)
276. Rizzardi LF, Cook JG. 2012 Flipping the switch from G1 to S phase with E3 ubiquitin ligases. Genes Cancer 3, 634-648. (doi:10.1177/1947601912473307)
277. Abbas T, Shibata E, Park J, Jha S, Karnani N, Dutta A. 2010 CRL4Cdt2 regulates cell proliferation and histone gene expression by targeting PR-Set7/Set8 for degradation. Mol. Cell 40, 9-21. (doi:10.1016/j.molcel.2010.09.014)
278. Tardat M, Brustel J, Kirsh O, Lefevbre C, Callanan M, Sardet C, Julien E. 2010 The histone H4 Lys 20 methyltransferase PR-Set7 regulates replication origins in mammalian cells. Nat. Cell Biol. 12, 1086-1093. (doi:10.1038/ncb2113)
279. Zhu W, Dutta A. 2006 An ATR- and BRCA1-mediated Fanconi anemia pathway is required for activating the G2/M checkpoint and DNA damage repair upon rereplication. Mol. Cell. Biol. 26, 4601-4611. (doi:10.1128/MCB.02141-05)
280. Milhollen MA, Narayanan U, Soucy TA, Veiby PO, Smith PG, Amidon B. 2011 Inhibition of NEDD8-activating enzyme induces rereplication and apoptosis in human tumor cells consistent with deregulating CDT1 turnover. Cancer Res. 71, 3042-3051. (doi:10.1158/0008-5472.CAN-10-2122)
281. Jia L, Li H. 2011 Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression. Neoplasia (New York, NY) 13, 561-569. (doi:10.1593/neo.11420)
282. Priego Moreno S, Bailey R, Campion N, Herron S, Gambus A. 2014 Polyubiquitylation drives replisome disassembly at the termination of DNA replication. Science 346, 477-481. (doi:10.1126/science.1253585)
283. Maric M, Maculins T, De Piccoli G, Labib K. 2014 Cdc48 and a ubiquitin ligase drive disassembly of the CMG helicase at the end of DNA replication. Science 346, 1253596. (doi:10.1126/science.1253596)
284. Archambault V, Ikui A, Drapkin B, Cross F. 2005 Disruption of mechanisms that prevent rereplication triggers a DNA damage response. Mol. Cell 25, 6707-6721. (doi:10.1128/MCB.25.15.6707-6721.2005)
285. Blank JL et al. 2013 Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924. Cancer Res. 73, 225-234. (doi:10.1158/0008-5472.CAN-12-1729)
286. Zhao Y, Morgan MA, Sun Y. 2014 Targeting neddylation pathways to inactivate cullin-RING ligases for anticancer therapy. Antioxid. Redox Signal. 21, 2383-2400. (doi:10.1089/ars.2013.5795)
287. Swords RT et al. In press. Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study. Br. J. Haematol. (doi:10.1111/bjh.13323)
288. Xirodimas DP, Saville MK, Bourdon J-C, Hay RT, Lane DP. 2004 Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell 118, 83-97. (doi:10.1016/j.cell.2004.06.016)
289. Sundqvist A, Liu G, Mirsaliotis A, Xirodimas DP. 2009 Regulation of nucleolar signalling to p53 through NEDDylation of L11. EMBO Rep. 10, 1132-1139. (doi:10.1038/embor.2009.178)
290. Ma T, Chen Y, Zhang F, Yang C, Wang S, Yu X. 2013 RNF111-dependent neddylation activates DNA damage-induced ubiquitination. Mol. Cell 49, 897-907. (doi:10.1016/j.molcel.2013.01.006)
291. Enchev RI, Schulman BA, Peter M. 2014 Protein neddylation: beyond cullin-RING ligases. Nat. Rev. Mol. Cell Biol. 16, 30-44. (doi:10.1038/nrm3919)
292. Liu L et al. 2009 CUL4A abrogation augments DNA damage response and protection against skin carcinogenesis. Mol. Cell 34, 451-460. (doi:10.1016/j.molcel.2009.04.020)
293. Yin Y et al. 2011 The E3 ubiquitin ligase cullin 4A regulates meiotic progression in mouse spermatogenesis. Dev. Biol. 356, 51-62. (doi:10.1016/j.ydbio.2011.05.661)
294. Tarpey PS et al. 2007 Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. Am. J. Hum. Genet. 80, 345-352. (doi:10.1086/511134)
295. Liu L, Yin Y, Li Y, Prevedel L, Lacy EH, Ma L, Zhou P. 2012 Essential role of the CUL4B ubiquitin ligase in extra-embryonic tissue development during mouse embryogenesis. Cell Res. 22, 1258-1269. (doi:10.1038/cr.2012.48)
296. Groisman R, Polanowska J, Kuraoka I, Sawada J, Saijo M, Drapkin R, Kisselev AF, Tanaka K, Nakatani Y. 2003 The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 113, 357-367. (doi:10.1016/S0092-8674(03)00316-7)
297. Yeh JI et al. 2012 Damaged DNA induced UVdamaged DNA-binding protein (UV-DDB) dimerization and its roles in chromatinized DNA repair. Proc. Natl Acad. Sci. USA 109, E2737-E2746. (doi:10.1073/pnas.1110067109)
298. Sugasawa K et al. 2005 UV-induced ubiquitylation of XPC protein mediated by UV-DDB-ubiquitin ligase complex. Cell 121, 387-400. (doi:10.1016/j.cell.2005.02.035)
299. Wang H, Zhai L, Xu J, Joo H-Y, Jackson S, Erdjument-Bromage H, Tempst P, Xiong Y, Zhang Y. 2006 Histone H3 and H4 ubiquitylation by the CUL4-DDB-ROC1 ubiquitin ligase facilitates cellular response to DNA damage. Mol. Cell 22, 383-394. (doi:10.1016/j.molcel.2006.03.035)
300. Tang J, Chu G. 2002 Xeroderma pigmentosum complementation group E and UV-damaged DNAbinding protein. DNA Repair 1, 601-616. (doi:10.1016/S1568-7864(02)00052-6)
301. Scrima A et al. 2008 Structural basis of UV DNAdamage recognition by the DDB1-DDB2 complex. Cell 135, 1213-1223. (doi:10.1016/j.cell.2008.10.045)
302. Tornaletti S. 2009 DNA repair in mammalian cells: transcription-coupled DNA repair: directing your effort where it's most needed. Cell. Mol. Life Sci. 66, 1010-1020. (doi:10.1007/s00018-009-8738-x)
303. Havens CG, Walter JC. 2011 Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase. Genes Dev. 25, 1568-1582. (doi:10.1101/gad.2068611)
304. Ulrich HD. 2014 Two-way communications between ubiquitin-like modifiers and DNA. Nat. Struct. Mol. Biol. 21, 317-324. (doi:10.1038/nsmb.2805)
305. Sancar A, Lindsey-Boltz LA, Unsal-Kaçmaz K, Linn S. 2004 Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73, 39-85. (doi:10.1146/annurev. biochem.73.011303.073723)
306. Mailand N, Bekker-Jensen S, Bartek J, Lukas J. 2006 Destruction of Claspin by SCFbTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress. Mol. Cell 23, 307-318. (doi:10.1016/j.molcel.2006.06.016)
307. Peschiaroli A, Dorrello NV, Guardavaccaro D, Venere M, Halazonetis T, Sherman NE, Pagano M. 2006 SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. Mol. Cell 23, 319-329. (doi:10.1016/j.molcel.2006.06.013)
308. Postow L, Funabiki H. 2013 An SCF complex containing Fbxl12 mediates DNA damage-induced Ku80 ubiquitylation. Cell Cycle 12, 587-595. (doi:10.4161/cc.23408)
309. Postow L, Ghenoiu C, Woo EM, Krutchinsky AN, Chait BT, Funabiki H. 2008 Ku80 removal from DNA through double strand break-induced ubiquitylation. J. Cell Biol. 182, 467-479. (doi:10.1083/jcb.200802146)
310. Postow L. 2012 Destroying the ring: freeing DNA from Ku with ubiquitin. FEBS Lett. 585, 2876-2882. (doi:10.1016/j.febslet.2011.05.046)
311. Walker JR, Corpina RA, Goldberg J. 2001 Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature 412, 607-614. (doi:10.1038/35088000)
312. Frit P, Li RY, Arzel D, Salles B, Calsou P. 2000 Ku entry into DNA inhibits inward DNA transactions in vitro. J. Biol. Chem. 275, 35 684-35 691. (doi:10.1074/jbc.M004315200)
313. Ono M, Tucker PW, Capra JD. 1996 Ku is a general inhibitor of DNA-protein complex formation and transcription. Mol. Immunol. 33, 787-796. (doi:10.1016/0161-5890(96)00030-2)
314. Garcia K et al. 2014 Nedd8-activating enzyme inhibitor MLN4924 provides synergy with mitomycin C through interactions with ATR, BRCA1/BRCA2 and chromatin dynamics pathways. Mol. Cancer Ther. 13, 1625-1635. (doi:10.1158/1535-7163.MCT-13-0634)
315. Guihard S, Ramolu L, Macabre C, Wasylyk B, Noël G, Abecassis J, Jung AC. 2012 The NEDD8 conjugation pathway regulates p53 transcriptional activity and head and neck cancer cell sensitivity to ionizing radiation. Int. J. Oncol. 41, 1531-1540. (doi:10.3892/ijo.2012.1584)
316. Jazaeri A et al. 2013 Overcoming platinum resistance in preclinical models of ovarian cancer using the neddylation inhibitor MLN4924. Mol. Cancer Ther 12, 1958-1967. (doi:10.1158/1535-7163.MCT-12-1028)
317. Kee Y, Huang M, Chang S, Moreau LA, Park E, Smith PG, D'Andrea AD. 2012 Inhibition of the Nedd8 system sensitizes cells to DNA interstrand crosslinking agents. Mol. Cancer Res. 10, 369-377. (doi:10.1158/1541-7786.MCR-11-0497)
318. Nawrocki ST et al. 2013 Disrupting protein NEDDylation with MLN4924 is a novel strategy to target cisplatin resistance in ovarian cancer. Clin. Cancer Res. 19, 3577. (doi:10.1158/1078-0432.CCR-12-3212)
319. Pan W-W, Zhou J-J, Yu C, Xu Y, Guo L-J, Zhang H-Y, Zhou D, Song F-Z, Fan H-Y. 2013 Ubiquitin E3 ligase CRL4CDT2/DCAF2 as a potential chemotherapeutic target for ovarian surface epithelial cancer. J. Biol. Chem. 288, 29 680-29 691. (doi:10.1074/jbc.M113.495069)
320. Wei D, Li H, Yu J, Sebolt JT, Zhao L, Lawrence TS, Smith PG, Morgan MA, Sun Y. 2011 Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor. Cancer Res. 72, 282-293. (doi:10.1158/0008-5472.CAN-11-2866)
321. Yang D, Tan M, Wang G, Sun Y. 2012 The p21-dependent radiosensitization of human breast cancer cells by MLN4924, an investigational inhibitor of NEDD8 activating enzyme. PLoS ONE 7, e34079. (doi:10.1371/journal.pone.0034079)
322. Koinuma D, Shinozaki M, Komuro A. 2003 Arkadia amplifies TGF-b superfamily signalling through degradation of Smad7. EMBO J. 22, 6458-6470. (doi:10.1093/emboj/cdg632)
323. Erker Y, Neyret-Kahn H, Seeler JS, Dejean A, Atfi A, Levy L. 2013 Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation. Mol. Cell. Biol. 33, 2163-2177. (doi:10.1128/MCB.01019-12)
324. Scott DC, Sviderskiy VO, Monda JK, Lydeard JR, Cho SE, Harper JW, Schulman BA. 2014 Structure of a RING E3 trapped in action reveals ligation mechanism for the ubiquitin-like protein NEDD8. Cell 157, 1671-1684. (doi:10.1016/j.cell.2014.04.037)
325. Wu J et al. 2012 Skp2 E3 ligase integrates ATM activation and homologous recombination repair by ubiquitinating NBS1. Mol. Cell 46, 1-11. (doi:10.1016/j.molcel.2012.03.022)
326. Lu C-S et al. 2012 The RING finger protein RNF8 ubiquitinates Nbs1 to promote DNA double-strand break repair by homologous recombination. J. Biol. Chem. 287, 43 984-43 994. (doi:10.1074/jbc.M112.421545)
327. Jimeno S, Fernandez-Avila MJ, Cruz-Garcia A, Cepeda-Garcia C, Gomez-Cabello D, Huertas P. 2015 Neddylation inhibits CtIP-mediated resection and regulates DNA double strand break repair pathway choice. Nucleic Acids Res 43, 987-999. (doi:10.10. 1093/nar/gku1384)
328. Li T, Guan J, Huang Z, Hu X, Zheng X. 2014 RNF168-mediated H2A neddylation antagonizes its ubiquitination and regulates DNA damage repair. J. Cell Sci. 127, 2238-2248. (doi:10.1242/jcs.138891)
329. Jackson SP, Durocher D. 2013 Regulation of DNA damage responses by ubiquitin and SUMO. Mol. Cell 49, 795-807. (doi:10.1016/j.molcel.2013.01.017)
330. Doudna JA, Charpentier E. 2014 The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096. (doi:10.1126/science.1258096)
331. Hsu PD, Lander ES, Zhang F. 2014 Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262-1278. (doi:10.1016/j.cell.2014.05.010)